Beam Therapeutics Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 |
|---|---|---|---|---|
| Revenue | $7.7M | $11.9M | $10.1M | $35.0M |
| Revenue_Source_1 | $7.7M | $11.9M | $10.1M | $35.0M |
| Revenue_Source_2 | $0 | $0 | $0 | $0 |
| Cost of Revenue | — | — | — | — |
| Gross Profit | — | — | — | — |
| Gross Margin | — | — | — | — |
| Operating Expenses | ||||
| Research & Development | — | — | — | — |
| SG&A Expense | — | — | — | — |
| Operating Income | — | — | — | — |
| Operating Margin | — | — | — | — |
| Interest Expense | — | — | — | — |
| Pretax Income | — | — | — | — |
| Income Tax Expense | — | — | — | — |
| Net Income | — | — | — | — |
| Net Margin | — | — | — | — |
| EPS (Basic) | — | — | — | — |
| EPS (Diluted) | — | — | — | — |
| Shares Outstanding (Basic) | — | — | — | — |
| Shares Outstanding (Diluted) | — | — | — | — |
| Dividends Per Share | — | — | — | — |